Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO)

Historical Holders from Q1 2016 to Q2 2025

Symbol: CDMO
Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 64,369,712
All holders as of 30 Jun 2025: Q2 2025
Total 13F shares, excl. options: 0
Holdings value: $0
Number of holders: 0
Number of sells: -2
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
AltraVue Capital, LLC	5.9%		$47,190,485		3,797,813		AltraVue Capital, LLC	31 Dec 2024

Institutional Holders of Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q2	0	$0	-$2,310				0
2025 Q1	187	$2,310	-$824,589,287	$0	$0	$12.43	2
2024 Q4	67,862,725	$838,118,292	+$9,853,050	$56,810	$2,661,425	$12.35	195
2024 Q3	68,016,155	$773,947,096	+$65,075,263	$1,345,850	$1,023,062	$11.38	171
2024 Q2	65,072,173	$464,610,616	+$2,556,922	$787,542	$152,082	$7.14	167
2024 Q1	65,068,905	$435,959,854	+$52,291,806	$680,050	$338,350	$6.7	162
2023 Q4	57,332,577	$373,979,029	-$54,052,092	$81,900	$172,900	$6.5	171
2023 Q3	62,604,660	$590,964,703	-$26,582,219	$45,312	$55,696	$9.44	166
2023 Q2	64,851,861	$906,098,576	-$203,208	$608,477	$300,355	$13.97	164
2023 Q1	64,584,658	$1,211,388,533	-$7,196,779	$960,512	$671,608	$18.76	166
2022 Q4	65,304,421	$899,318,344	+$3,894,302	$363,528	$414,477	$13.77	162
2022 Q3	64,309,645	$1,229,047,447	+$30,714,400	$80,000	$533,000	$19.12	168
2022 Q2	61,099,678	$932,609,878	-$12,928,155	$252,000	$154,000	$15.26	180
2022 Q1	61,944,273	$1,262,212,725	-$11,767,975	$0	$4,007,000	$20.37	182
2021 Q4	61,292,159	$1,785,416,483	+$224,167,054	$306,000	$3,838,000	$29.18	184
2021 Q3	53,889,335	$1,161,457,403	+$19,405,092	$0	$5,336,000	$21.57	154
2021 Q2	52,834,820	$1,353,592,887	+$137,037,774	$4,364,000	$5,690,000	$25.65	167
2021 Q1	47,706,252	$870,108,293	+$164,156,116	$261,000	$2,536,000	$18.23	152
2020 Q4	39,269,337	$453,350,286	+$67,918,429	$268,000	$355,000	$11.54	141
2020 Q3	33,338,151	$254,061,025	+$32,454,270	$358,000	$376,000	$7.62	104
2020 Q2	29,117,143	$191,764,644	+$5,672,161	$425,000	$782,000	$6.56	95
2020 Q1	28,279,005	$144,444,796	-$6,179,021	$202,000	$237,000	$5.11	89
2019 Q4	28,687,052	$219,999,260	+$25,179,108	$93,000	$539,000	$7.67	105
2019 Q3	25,297,730	$133,946,899	+$6,955,012	$64,000	$201,000	$5.3	90
2019 Q2	23,840,831	$133,510,921	+$16,544,433		$216,000	$5.6	86
2019 Q1	21,669,771	$92,077,139	-$4,951,613		$136,000	$4.25	88
2018 Q4	22,411,743	$91,847,919	+$1,141,125	$0	$117,000	$4.1	93
2018 Q3	16,666,361	$114,325,369	+$33,609,807	$525,000	$403,000	$6.86	93
2018 Q2	12,063,396	$47,294,157	+$7,659,118	$362,000	$126,000	$3.92	68
2018 Q1	10,528,593	$30,755,800	+$28,250,800	$94,000	$185,000	$2.92	56
2017 Q4	257,323	$993,000	+$958,000			$3.87	3
2016 Q2	0	$0	-$17,000				0
2016 Q1	4,000	$17,000				$4.25	1